TickerGuard
Buy Day today: Poor (44) Weak market breadth · no major macro event
ADRX

ADARx Pharmaceuticals, Inc.

Healthcare · Biotechnology

14.00$ -1.4% vs. previous close Closing price · As of: Nov 16, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow ADRX
Line item Q1 25 Q2 25 Q1 26 Q2 26
– 150,694.2% -1,059.8% -3,644.9%
– 301.0% 33.6% 98.5%
– 551.0% 39.1% 201.9%
– 158,910.1% -63.5% -481.8%
– 476.9% 3.6% 49.2%
– 39.9% 0.1% 0.8%
– 24,221.2% -124.3% -720.4%
– 150,217.3% -1,063.4% -3,694.1%

Data as of: November 16, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?